Skip to Content
Biotechnology and health

The US government claims it’s swabbing the cheeks of immigrants to match them using DNA

The Department of Health and Human Services says it’s using DNA tests to help reunite 3,000 immigrant children separated from their parents—but won’t say who is doing the tests.

The situation: The agency is under an order from a US. federal district court to reunite alien minors under five years old with their parents. It says DNA tests are a fast way to do it.

The background: Immigrants frequently pay for DNA tests to establish that they’re related to someone in the US. However, genetic tests have never been used to untangle a mass round-up like this one.

Ethical problems: Testing a child’s DNA requires consent of a parent or guardian. Without knowing who the children’s parents are, it’s unclear how the US government can obtain that consent. “If a child can’t verbalize who their parent is, DNA is an excellent way to find out,” says Michael Baird, chief science officer of DNA Diagnostics Center, a testing company based in Ohio. “But I don’t know how a child under five, or even over five, can legally consent to a test.” Nevertheless, federal law states that unaccompanied kids in HHS’s custody are the agency’s responsibility, and it can place them in foster homes and make medical decisions for them. That could include taking their DNA.

How the tests work: Identification tests look at a dozen genetic markers calls short-tandem repeats, or STRs. They’re the same kind used in paternity disputes and by police. STRs don’t contain any health information. The government says the testing results on immigrants will be discarded later.

Results so far: According to HHS, some people claiming to be parents aren’t really—and a few have already admitted it when asked to take a DNA test. On July 10, the agency said 34 parents had already cleared a criminal check and taken a DNA test linking them to their kids.

The mystery: HHS has refused to say who is performing the tests. Although the DNA tests themselves are mostly infallible, the logistics of keeping track of everyone’s samples isn’t. A mix-up could lead to a wrong conclusion that a parent and child aren’t actually related.

Deep Dive

Biotechnology and health

How scientists traced a mysterious covid case back to six toilets

When wastewater surveillance turns into a hunt for a single infected individual, the ethics get tricky.

An AI-driven “factory of drugs” claims to have hit a big milestone

Insilico is part of a wave of companies betting on AI as the "next amazing revolution" in biology

The quest to legitimize longevity medicine

Longevity clinics offer a mix of services that largely cater to the wealthy. Now there’s a push to establish their work as a credible medical field.

There is a new most expensive drug in the world. Price tag: $4.25 million

But will the latest gene therapy suffer the curse of the costliest drug?

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at with a list of newsletters you’d like to receive.